RECRUITING

Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The research is studying virtual reality (VR)-directed brain-gut behavioral therapy (BGBT) as a pain treatment option for hospitalized patients with inflammatory bowel disease (IBD). This study is being done to learn if VR-directed BGBT is feasible and acceptable for patients with IBD in addressing pain in the hospital setting. The study hypothesizes that: * At least 75% of enrolled participants will complete the VR-directed BGBT inpatient program * Hospitalized patients with IBD will find VR-directed BGBT acceptable as a pain treatment option in the inpatient setting.

Official Title

Evaluation of a Virtual Reality-Directed Brain Gut Behavioral Treatment Inpatient Program for Patients With Inflammatory Bowel Disease

Quick Facts

Study Start:2024-02-13
Study Completion:2025-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06188793

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients with Inflammatory Bowel Disease and self-reported pain
  2. * Hospitalized for management of IBD (inpatient medicine services at Michigan Medicine)
  1. * Patients that do not report pain
  2. * Anticipated length of hospital stay is less than 72 hours
  3. * Patients that have previously had a seizure, loss of awareness, or other symptoms linked to an epileptic condition
  4. * Patients with binocular vision loss
  5. * Patients with an uncontrolled cardiac condition such as an arrhythmia, coronary artery disease, or neurological/cerebrovascular disease.
  6. * Patients that are currently pregnant

Contacts and Locations

Study Contact

Shirley Cohen-Mekelburg, MD, MS
CONTACT
734-845-5735
shcohen@med.umich.edu

Principal Investigator

Shirley Cohen-Mekelburg, MD, MS
PRINCIPAL_INVESTIGATOR
University of Michigan

Study Locations (Sites)

University of Michigan
Ann Arbor, Michigan, 48109
United States

Collaborators and Investigators

Sponsor: University of Michigan

  • Shirley Cohen-Mekelburg, MD, MS, PRINCIPAL_INVESTIGATOR, University of Michigan

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-13
Study Completion Date2025-07

Study Record Updates

Study Start Date2024-02-13
Study Completion Date2025-07

Terms related to this study

Keywords Provided by Researchers

  • Virtual reality
  • Inpatient
  • Pain
  • Brain Gut Behavioral Treatment

Additional Relevant MeSH Terms

  • Inflammatory Bowel Diseases